Endophthalmitis. A review of current evaluation and management.
Lemley CA et al（WI USA)
Retina 27(6): 662-80, 2007
・白内障術後、硝子体内注射、外傷、全身的な感染症後に発症する眼内炎の治療のレビュー。
Topical   Subconjunctival  Intravitreal
Amikacin             20 mg/mL          40 mg                400 μg
Amphotericin B  0.15-0.5%                                      5-10 μg
Ampicillin            50 mg/mL          100 mg                5 mg
Cefamandole       50 mg/mL          75 mg                 2 mg
Cefazolin             50 mg/mL          100 mg               2.25 mg
Ceftazidime         50 mg/mL          100 mg               2.25 mg
Ciprofloxacin      0.3% solution      1 mg*               100-500 μg*
Clindamycin                                    30 mg                250 μg
Fluconazole        0.2% solution     2%-1 mL             10-100 μg*
Gatifloxacin        0.3% solution                                  400 μg*
Gentamicin         10-20 mg/mL       20 mg                200 μg
Levofloxacin       0.5% solution                                  625 μg*
Linezolid                                          400 μg*
Methicillin          1 % solution        100 mg                2 mg
Miconazole          10 mg/mL           5 mg                 25 μg
Moxifloxacin       0.5% solution                                  400 μ g*
Tobramycin        8-15 mg/mL         20 mg                200 μg
Vancomycin         50 mg/mL          25 mg                  1 mg
Voriconazole        1-2% solution                                  100 μg
*Extrapolated from animal studies.